id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2022-0061-0004,APHIS,APHIS-2022-0061,US SHIP Program Standards,Supporting & Related Material,Guidance,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T14:13:38Z,,0,0,0900006486888ffb
APHIS-2023-0088-0004,APHIS,APHIS-2023-0088,Biosecurity Audit Tool,Supporting & Related Material,Supplement,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T14:16:16Z,,0,0,090000648688880f
APHIS-2022-0061-0002,APHIS,APHIS-2022-0061,PRA Abstract,Supporting & Related Material,Paperwork Packages,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T14:13:21Z,,0,0,0900006486888ffd
APHIS-2023-0088-0003,APHIS,APHIS-2023-0088,Information Collection Abstract,Supporting & Related Material,Paperwork Packages,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T14:16:11Z,,0,0,0900006486888a96
APHIS-2023-0088-0002,APHIS,APHIS-2023-0088,Initial Regulatory Flexibility Analysis (Economic Analysis),Supporting & Related Material,Economic Analysis,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T14:16:02Z,,0,0,0900006486888ffa
APHIS-2022-0061-0003,APHIS,APHIS-2022-0061,Initial Economic Analysis,Supporting & Related Material,Economic Analysis,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T14:13:32Z,,0,0,0900006486888ffc
EPA-HQ-OPPT-2024-0501-0003,EPA,EPA-HQ-OPPT-2024-0501,"High-Priority Substance Designations Under the Toxic Substances Control Act (TSCA) and Initiation of Risk Evaluation on High-Priority Substances; Notice of Availability, December 2024",Supporting & Related Material,Publication - Previous/Related FR Notice,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:45:59Z,,0,0,090000648687c2b9
EPA-HQ-OPPT-2024-0501-0007,EPA,EPA-HQ-OPPT-2024-0501,"Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, 4,4′-Methylene bis(2-chloroaniline) (MBOCA), CAS #: 101-14-4",Supporting & Related Material,Data,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:47:04Z,,0,0,090000648687c2f9
EPA-HQ-OPPT-2024-0501-0004,EPA,EPA-HQ-OPPT-2024-0501,"Fees for the Administration of the Toxic Substances Control Act Final Rule, October 2018",Supporting & Related Material,Publication - Previous/Related FR Notice,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:45:46Z,,0,0,090000648687c2ba
EPA-HQ-OPPT-2024-0501-0005,EPA,EPA-HQ-OPPT-2024-0501,"Initiation of Prioritization Under the Toxic Substances Control Act (TSCA); Request for Comment, December 2023",Supporting & Related Material,Publication - Previous/Related FR Notice,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:47:30Z,,0,0,090000648687c2bb
EPA-HQ-OPPT-2024-0501-0009,EPA,EPA-HQ-OPPT-2024-0501,"Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Benzenamine, CAS #: 62-53-3",Supporting & Related Material,Data,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:46:38Z,,0,0,090000648687c2fb
EPA-HQ-OPPT-2024-0501-0002,EPA,EPA-HQ-OPPT-2024-0501,"Fees for the Administration of the Toxic Substances Control Act (TSCA) Final Rule, February 2024",Supporting & Related Material,Publication - Previous/Related FR Notice,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:46:12Z,,0,0,090000648687c2b8
EPA-HQ-OPPT-2024-0501-0008,EPA,EPA-HQ-OPPT-2024-0501,"Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acrylonitrile, CAS #: 107-13-1",Supporting & Related Material,Data,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:47:17Z,,0,0,090000648687c2fa
EPA-R09-OW-2023-0623-0109,EPA,EPA-R09-OW-2023-0623,Response to Comments CTV-I 26R (12.30.24),Supporting & Related Material,,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:54:39Z,,0,0,090000648689625e
EPA-HQ-OPPT-2024-0501-0006,EPA,EPA-HQ-OPPT-2024-0501,"Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acetaldehyde, CAS #: 75-07-0",Supporting & Related Material,Data,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:46:25Z,,0,0,090000648687c2f8
EPA-HQ-OPPT-2024-0501-0010,EPA,EPA-HQ-OPPT-2024-0501,"Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Vinyl Chloride, CAS #: 75-01-4",Supporting & Related Material,Data,2024-12-31T05:00:00Z,2024,12,,,2025-01-01T01:46:51Z,,0,0,090000648687c2fc
FDA-2022-N-2390-0097,FDA,FDA-2022-N-2390,Exhibit 208,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:54Z,,0,0,09000064868a2ef0
FDA-2022-N-2390-0128,FDA,FDA-2022-N-2390,Exhibit 239,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:26Z,,0,0,09000064868a2f37
FDA-2022-N-2390-0123,FDA,FDA-2022-N-2390,Exhibit 234,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:56Z,,0,0,09000064868a2f32
FDA-2022-N-2390-0126,FDA,FDA-2022-N-2390,Exhibit 237,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:37Z,,0,0,09000064868a2f35
FDA-2022-N-2390-0090,FDA,FDA-2022-N-2390,Exhibit 201,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:04Z,,0,0,09000064868a2ee9
FDA-2022-N-2390-0096,FDA,FDA-2022-N-2390,Exhibit 207,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:48Z,,0,0,09000064868a2eef
FDA-2022-N-2390-0127,FDA,FDA-2022-N-2390,Exhibit 238,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:31Z,,0,0,09000064868a2f36
FDA-2022-N-2390-0088,FDA,FDA-2022-N-2390,Exhibit 199,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:52Z,,0,0,09000064868a3103
FDA-2022-N-2390-0103,FDA,FDA-2022-N-2390,Exhibit 214,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:27Z,,0,0,09000064868a2f07
FDA-2022-N-2390-0115,FDA,FDA-2022-N-2390,Exhibit 226,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:14Z,,0,0,09000064868a2f1d
FDA-2022-N-2390-0101,FDA,FDA-2022-N-2390,Exhibit 212,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:37Z,,0,0,09000064868a2f05
FDA-2022-N-2390-0107,FDA,FDA-2022-N-2390,Exhibit 218,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:05Z,,0,0,09000064868a2f0b
FDA-2022-N-2390-0120,FDA,FDA-2022-N-2390,Exhibit 231,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:47Z,,0,0,09000064868a2f2f
FDA-2022-N-2390-0105,FDA,FDA-2022-N-2390,Exhibit 216,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:18Z,,0,0,09000064868a2f09
FDA-2022-N-2390-0106,FDA,FDA-2022-N-2390,Exhibit 217,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:11Z,,0,0,09000064868a2f0a
FDA-2022-N-2390-0111,FDA,FDA-2022-N-2390,Exhibit 222,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:39Z,,0,0,09000064868a2f19
FDA-2022-N-2390-0113,FDA,FDA-2022-N-2390,Exhibit 224,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:26Z,,0,0,09000064868a2f1b
FDA-2022-N-2390-0079,FDA,FDA-2022-N-2390,Exhibit 190,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:08Z,,0,0,09000064868a27cf
FDA-2022-N-2390-0084,FDA,FDA-2022-N-2390,Exhibit 195,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:11Z,,0,0,09000064868a28ff
FDA-2022-N-2390-0098,FDA,FDA-2022-N-2390,Exhibit 209,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:59Z,,0,0,09000064868a2ef1
FDA-2022-N-2390-0074,FDA,FDA-2022-N-2390,Index to Exhibits,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:25:42Z,,0,0,09000064868a4593
FDA-2022-N-2390-0080,FDA,FDA-2022-N-2390,Exhibit 191,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:13Z,,0,0,09000064868a28fb
FDA-2022-N-2390-0085,FDA,FDA-2022-N-2390,Exhibit 196,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:17Z,,0,0,09000064868a3100
FDA-2022-N-2390-0100,FDA,FDA-2022-N-2390,Exhibit 211,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:11Z,,0,0,09000064868a2f04
FDA-2022-N-2390-0102,FDA,FDA-2022-N-2390,Exhibit 213,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:32Z,,0,0,09000064868a2f06
FDA-2022-N-2390-0104,FDA,FDA-2022-N-2390,Exhibit 215,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:32:23Z,,0,0,09000064868a2f08
FDA-2022-N-2390-0112,FDA,FDA-2022-N-2390,Exhibit 223,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:32Z,,0,0,09000064868a2f1a
FDA-2022-N-2390-0114,FDA,FDA-2022-N-2390,Exhibit 225,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:20Z,,0,0,09000064868a2f1c
FDA-2022-N-2390-0117,FDA,FDA-2022-N-2390,Exhibit 228,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:03Z,,0,0,09000064868a2f1f
FDA-2022-N-2390-0083,FDA,FDA-2022-N-2390,Exhibit 194,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:40Z,,0,0,09000064868a28fe
FDA-2022-N-2390-0094,FDA,FDA-2022-N-2390,Exhibit 205,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:37Z,,0,0,09000064868a2eed
FDA-2022-N-2390-0089,FDA,FDA-2022-N-2390,Exhibit 200,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:58Z,,0,0,09000064868a3104
FDA-2022-N-2390-0075,FDA,FDA-2022-N-2390,Exhibit 186,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:25:49Z,,0,0,09000064868a27cb
FDA-2022-N-2390-0076,FDA,FDA-2022-N-2390,Exhibit 187,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:25:55Z,,0,0,09000064868a27cc
FDA-2022-N-2390-0099,FDA,FDA-2022-N-2390,Exhibit 210,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:05Z,,0,0,09000064868a2ef2
FDA-2022-N-2390-0124,FDA,FDA-2022-N-2390,Exhibit 235,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:49Z,,0,0,09000064868a2f33
FDA-2022-N-2390-0122,FDA,FDA-2022-N-2390,Exhibit 233,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:36Z,,0,0,09000064868a2f31
FDA-2022-N-2390-0109,FDA,FDA-2022-N-2390,Exhibit 220,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:53Z,,0,0,09000064868a2f0d
FDA-2022-N-2390-0086,FDA,FDA-2022-N-2390,Exhibit 197,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:27Z,,0,0,09000064868a3101
FDA-2022-N-2390-0092,FDA,FDA-2022-N-2390,Exhibit 203,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:18Z,,0,0,09000064868a2eeb
FDA-2022-N-2390-0095,FDA,FDA-2022-N-2390,Exhibit 206,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:43Z,,0,0,09000064868a2eee
FDA-2022-N-2390-0129,FDA,FDA-2022-N-2390,Exhibit 240,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:19Z,,0,0,09000064868a2f38
FDA-2022-N-2390-0093,FDA,FDA-2022-N-2390,Exhibit 204,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:32Z,,0,0,09000064868a2eec
FDA-2022-N-2390-0116,FDA,FDA-2022-N-2390,Exhibit 227,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:09Z,,0,0,09000064868a2f1e
FDA-2022-N-2390-0118,FDA,FDA-2022-N-2390,Exhibit 229,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:57Z,,0,0,09000064868a2f20
FDA-2022-N-2390-0110,FDA,FDA-2022-N-2390,Exhibit 221,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:47Z,,0,0,09000064868a2f18
FDA-2022-N-2390-0121,FDA,FDA-2022-N-2390,Exhibit 232,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:41Z,,0,0,09000064868a2f30
FDA-2022-N-2390-0078,FDA,FDA-2022-N-2390,Exhibit 189,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:07Z,,0,0,09000064868a27ce
FDA-2022-N-2390-0091,FDA,FDA-2022-N-2390,Exhibit 202,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:29:10Z,,0,0,09000064868a2eea
FDA-2022-N-2390-0125,FDA,FDA-2022-N-2390,Exhibit 236,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:43Z,,0,0,09000064868a2f34
FDA-2022-N-2390-0077,FDA,FDA-2022-N-2390,Exhibit 188,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:26:01Z,,0,0,09000064868a27cd
FDA-2022-N-2390-0081,FDA,FDA-2022-N-2390,Exhibit 192,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:20Z,,0,0,09000064868a28fc
FDA-2022-N-2390-0087,FDA,FDA-2022-N-2390,Exhibit 198,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:28:46Z,,0,0,09000064868a3102
FDA-2022-N-2390-0082,FDA,FDA-2022-N-2390,Exhibit 193,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:27:25Z,,0,0,09000064868a28fd
FDA-2022-N-2390-0119,FDA,FDA-2022-N-2390,Exhibit 230,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:30:51Z,,0,0,09000064868a2f21
FDA-2022-N-2390-0108,FDA,FDA-2022-N-2390,Exhibit 219,Supporting & Related Material,Background Material,2024-12-31T05:00:00Z,2024,12,,,2025-04-04T15:31:58Z,,0,0,09000064868a2f0c
FWS-HQ-ES-2023-0033-0013,FWS,FWS-HQ-ES-2023-0033,100-word summary blue tree monitor proposed listing rule,Supporting & Related Material,,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T13:35:26Z,,0,0,0900006486883163
FWS-HQ-ES-2023-0033-0011,FWS,FWS-HQ-ES-2023-0033,Emergency Petition to List the Blue Tree Monitor Lizard (Varanus Macraei) as Endangered Under the Endangered Species Act,Supporting & Related Material,,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T13:35:25Z,,0,0,090000648688208f
FWS-HQ-ES-2023-0033-0010,FWS,FWS-HQ-ES-2023-0033,Proposed Rule Literature Cited,Supporting & Related Material,,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T13:35:25Z,,0,0,0900006486881d13
FWS-HQ-ES-2023-0033-0012,FWS,FWS-HQ-ES-2023-0033,Draft Species Status Assessment for the Blue Tree Monitor (Varanus Macraei),Supporting & Related Material,,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T13:35:26Z,,0,0,0900006486882090
FWS-HQ-ES-2023-0033-0009,FWS,FWS-HQ-ES-2023-0033,Temporary Rule Emergency Action Literature Cited,Supporting & Related Material,,2024-12-31T05:00:00Z,2024,12,,,2024-12-31T13:34:59Z,,0,0,09000064868814ef
APHIS-2020-0024-0003,APHIS,APHIS-2020-0024,20-024-1 Pest Risk Assessment for Pineapple Importation from Indonesia,Supporting & Related Material,Risk Assessment,2024-12-30T05:00:00Z,2024,12,,,2024-12-30T14:27:07Z,,0,0,090000648687fab8
APHIS-2020-0024-0002,APHIS,APHIS-2020-0024,20-024-1 Risk Management Document for Pineapple Imortation from Indonesia,Supporting & Related Material,Risk Management Document,2024-12-30T05:00:00Z,2024,12,,,2024-12-30T14:26:52Z,,0,0,090000648687faba
APHIS-2020-0024-0004,APHIS,APHIS-2020-0024,20-024-1 Economic Effects Assessment for Pineapple Importation from Indonesia,Supporting & Related Material,Economic Analysis,2024-12-30T05:00:00Z,2024,12,,,2024-12-30T14:27:24Z,,0,0,090000648687fab7
EPA-R09-OAR-2024-0228-0065,EPA,EPA-R09-OAR-2024-0228,"D.21. Reasonable Further Progress: Rate-Of-Progress Plan, San Bernardino County Portion of the Southeast Desert AQMA (October 5, 1994)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:04:20Z,,0,0,090000648687aae9
EPA-R09-OAR-2024-0228-0044,EPA,EPA-R09-OAR-2024-0228,"D.1. Air Quality Implementation Plans; Restructuring SIP Preparation Regulations, 51 FR 40656 (November 7, 1986)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:08:50Z,,0,0,090000648687a9d0
EPA-R09-OAR-2024-0228-0047,EPA,EPA-R09-OAR-2024-0228,"D.5. Prevention of Significant Deterioration (PSD) and Nonattainment New Source Review (NSR), 61 FR 38250 (July 23, 1996)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:06:12Z,,0,0,090000648687aa7f
EPA-R09-OAR-2024-0228-0051,EPA,EPA-R09-OAR-2024-0228,"D.22. MDAQMD Federal 75 ppb Ozone Attainment Plan (Western Mojave Desert Nonattainment Area), adopted on 2/27/2017",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:06:24Z,,0,0,090000648687aa98
EPA-R09-OAR-2024-0228-0056,EPA,EPA-R09-OAR-2024-0228,"D.12. Federal Implementation Plan for Nonattainment New Source Review Program; Mojave Desert Air Quality Management District, California, 89 FR 56237 (July 9, 2024)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:09:15Z,,0,0,090000648687aa9d
EPA-R09-OAR-2024-0228-0074,EPA,EPA-R09-OAR-2024-0228,"D.35. Brief for Respondents, MDAQMD v. EPA, February 20, 2024",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:10:30Z,,0,0,090000648687aaf2
EPA-R09-OAR-2024-0228-0075,EPA,EPA-R09-OAR-2024-0228,"D.36. Petitioner’s Reply Brief, MDAQMD v. EPA, March 12, 2024",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:10:43Z,,0,0,090000648687aaf3
EPA-R09-OAR-2022-0338-0070,EPA,EPA-R09-OAR-2022-0338,G.06. Public Hearing Transcript of Federal Implementation Plan for the Mojave Desert Air Quality Management District’s Nonattainment New Source Review Program (7/24/2024),Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:00:53Z,,0,0,0900006486882f87
EPA-R09-OAR-2024-0228-0084,EPA,EPA-R09-OAR-2024-0228,"D.2. State Implementation Plans; General Preamble for the Implementation of Title I of the Clean Air Act Amendments of 1990, 57 FR 13498 (April 16, 1992)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T02:08:04Z,,0,0,09000064868955a6
EPA-R04-OAR-2021-0930-0020,EPA,EPA-R04-OAR-2021-0930,Appendix_E-2e_BMR5_Run6_For_SIP,Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:40:23Z,,0,0,090000648610f806
EPA-R04-OAR-2021-0930-0024,EPA,EPA-R04-OAR-2021-0930,Appendix_F-2f,Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:37:29Z,,0,0,090000648610f80a
EPA-R04-OAR-2021-0930-0043,EPA,EPA-R04-OAR-2021-0930,Appendix I-2,Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:45:02Z,,0,0,090000648610f81f
EPA-HQ-OLEM-2022-0174-0595,EPA,EPA-HQ-OLEM-2022-0174,"CSB Investigation Report: Catastrophic Rupture of Heat Exchanger (Seven Fatalities); Tesoro Anacortes Refinery, May 2014",Supporting & Related Material,Report,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:32:56Z,,0,0,090000648688093d
EPA-R04-OAR-2021-0930-0021,EPA,EPA-R04-OAR-2021-0930,Appendix_E-4_(MPE Deposition)_For_SIP,Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:40:35Z,,0,0,090000648610f807
EPA-HQ-OLEM-2022-0174-0594,EPA,EPA-HQ-OLEM-2022-0174,"CSB Safety Study: No. 2024-01-H; Remote Isolation of Process Equipment, July 2024",Supporting & Related Material,Study,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:33:09Z,,0,0,090000648688093c
EPA-R04-OAR-2021-0930-0045,EPA,EPA-R04-OAR-2021-0930,SIP 2024-01 Final  Submittal Letter Regional Haze Amendment,Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:46:04Z,,0,0,09000064865e5f10
EPA-R09-OAR-2022-0338-0083,EPA,EPA-R09-OAR-2022-0338,"G.49. Comment submitted by Karnig Ohannessian, Deputy Assistant Secretary of the Navy (Environment and Mission Readiness), U.S. Department of Defense on Federal Implementation Plan for Nonattainment New Source Review Program; Mojave Desert Air Quality Management District, California, 89 FR 56237 (June 9, 2024)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:56:48Z,,0,0,090000648688456d
EPA-R09-OAR-2022-0338-0096,EPA,EPA-R09-OAR-2022-0338,"G.11. Technical Support Document for EPA’s Notice of Proposed Rulemaking for the California State Implementation Plan Mojave Desert Air Quality Management District New Source Review (60 FR 55355 (October 31, 1995))",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:54:04Z,,0,0,09000064868845a8
EPA-R09-OAR-2022-0338-0113,EPA,EPA-R09-OAR-2022-0338,"G.07. OMB Non-Significance Determination for Final Federal Implementation Plan for Nonattainment New Source Review Program; Mojave Desert Air Quality Management District, California (11/14/2024)",Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:51:45Z,,0,0,09000064868916d0
EPA-R04-OAR-2021-0930-0008,EPA,EPA-R04-OAR-2021-0930,Appendix_D-2_AoI_and_HYSPLIT_graphics_for_VISTAS_and_Nearby_ClassI_Areas,Supporting & Related Material,,2024-12-30T05:00:00Z,2024,12,,,2024-12-31T01:38:06Z,,0,0,090000648610ea8b